Protective effect of hydrogen sulfide on the kidney (Review)
- Authors:
- Hu Zhang
- Haitian Zhao
- Nannan Guo
-
Affiliations: Department of Urology, General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group, Fuxin, Liaoning 123000, P.R. China, Department of Urology, The First Clinical Medical School of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Nephrology, General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group, Fuxin, Liaoning 123000, P.R. China - Published online on: August 3, 2021 https://doi.org/10.3892/mmr.2021.12335
- Article Number: 696
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Wang R: Gasotransmitters: Growing pains and joys. Trends Biochem Sci. 39:227–232. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Szabo C: A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator. Biochem Pharmacol. 149:5–19. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ngowi EE, Sarfraz M, Afzal A, Khan NH, Khattak S, Zhang X, Li T, Duan SF, Ji XY and Wu DD: Roles of hydrogen sulfide donors in common kidney diseases. Front Pharmacol. 11:5642812020. View Article : Google Scholar : PubMed/NCBI | |
|
Mao YG, Chen X, Zhang Y and Chen G: Hydrogen sulfide therapy: A narrative overview of current research and possible therapeutic implications in future. Med Gas Res. 10:185–188. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Paul BD and Snyder SH: Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol. 149:101–109. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wen YD, Wang H and Zhu YZ: The drug developments of hydrogen sulfide on cardiovascular disease. Oxid Med Cell Longev. 2018:40103952018. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar M and Sandhir R: Hydrogen sulfide in physiological and pathological mechanisms in brain. CNS Neurol Disord Drug Targets. 17:654–670. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yadav PK, Vitvitsky V, Carballal S, Seravalli J and Banerjee R: Thioredoxin regulates human mercaptopyruvate sulfurtransferase at physiologically-relevant concentrations. J Biol Chem. 295:6299–6311. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang R: Two's company, three's a crowd: Can H2S be the third endogenous gaseous transmitter? FASEB J. 16:1792–1798. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Li Q and Lancaster JR Jr: Chemical foundations of hydrogen sulfide biology. Nitric Oxide. 35:21–34. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mathai JC, Missner A, Kügler P, Saparov SM, Zeidel ML, Lee JK and Pohl P: No facilitator required for membrane transport of hydrogen sulfide. Proc Natl Acad Sci USA. 106:16633–16638. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Singh S, Padovani D, Leslie RA, Chiku T and Banerjee R: Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem. 284:22457–22466. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Módis K, Coletta C, Erdélyi K, Papapetropoulos A and Szabo C: Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J. 27:601–611. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Jhee KH and Kruger WD: Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine. J Biol Chem. 279:52082–52086. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chiku T, Padovani D, Zhu W, Singh S, Vitvitsky V and Banerjee R: H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J Biol Chem. 284:11601–11612. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Hsu A and Moore PK: Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases! Pharmacol Ther. 123:386–400. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Whiteman M, Le Trionnaire S, Chopra M, Fox B and Whatmore J: Emerging role of hydrogen sulfide in health and disease: Critical appraisal of biomarkers and pharmacological tools. Clin Sci (Lond). 121:459–488. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Schumann U and Subramani S: Special delivery from mitochondria to peroxisomes. Trends Cell Biol. 18:253–256. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kuang Q, Xue N, Chen J, Shen Z, Cui X, Fang Y and Ding X: Low plasma hydrogen sulfide is associated with impaired renal function and cardiac dysfunction. Am J Nephrol. 47:361–371. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F and Bouillaud F: Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta. 1797:1500–1511. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hildebrandt TM and Grieshaber MK: Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J. 275:3352–3361. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Libiad M, Yadav PK, Vitvitsky V, Martinov M and Banerjee R: Organization of the human mitochondrial hydrogen sulfide oxidation pathway. J Biol Chem. 289:30901–30910. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ziosi M, Di Meo I, Kleiner G, Gao XH, Barca E, Sanchez-Quintero MJ, Tadesse S, Jiang H, Qiao C, Rodenburg RJ, et al: Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway. EMBO Mol Med. 9:96–111. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kleiner G, Barca E, Ziosi M, Emmanuele V, Xu Y, Hidalgo-Gutierrez A, Qiao C, Tadesse S, Area-Gomez E, Lopez LC and Quinzii CM: CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway. Biochim Biophys Acta Mol Basis Dis. 1864:3708–3722. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Maldonato BJ, Russell DA and Totah RA: Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captopril. Sci Rep. 11:48572021. View Article : Google Scholar : PubMed/NCBI | |
|
Kabil O and Banerjee R: Redox biochemistry of hydrogen sulfide. J Biol Chem. 285:21903–21907. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Pushpakumar S, Kundu S and Sen U: Hydrogen sulfide protects hyperhomocysteinemia-induced renal damage by modulation of caveolin and eNOS interaction. Sci Rep. 9:22232019. View Article : Google Scholar : PubMed/NCBI | |
|
Xia M, Chen L, Muh RW, Li PL and Li N: Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther. 329:1056–1062. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Chen S, Liu H, Zhang B, Zhao Y, Ma K, Zhao D, Wang Q, Ma H and Zhang Z: Hydrogen sulfide prevents hydrogen peroxide-induced activation of epithelial sodium channel through a PTEN/PI(3,4,5)P3 dependent pathway. PLoS One. 8:e643042013. View Article : Google Scholar : PubMed/NCBI | |
|
Luo R, Hu S, Liu Q, Han M, Wang F, Qiu M, Li S, Li X, Yang T, Fu X, et al: Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration. FASEB J. 33:469–483. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ge SN, Zhao MM, Wu DD, Chen Y, Wang Y, Zhu JH, Cai WJ, Zhu YZ and Zhu YC: Hydrogen sulfide targets EGFR Cys797/Cys798 residues to induce Na(+)/K(+)-ATPase endocytosis and inhibition in renal tubular epithelial cells and increase sodium excretion in chronic salt-loaded rats. Antioxid Redox Signal. 21:2061–2082. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Li Y, Overstreet JM, Chung S, Niu A, Fan X, Wang S, Wang Y, Zhang MZ and Harris RC: Inhibition of epidermal growth factor receptor activation is associated with improved diabetic nephropathy and insulin resistance in type 2 diabetes. Diabetes. 67:1847–1857. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang ZJ, Chang LL, Wu J, Pan HM, Zhang QY, Wang MJ, Xin XM, Luo SS, Chen JA, Gu XF, et al: A novel rhynchophylline analog, Y396, inhibits endothelial dysfunction induced by oxidative stress in diabetes through epidermal growth factor receptor. Antioxid Redox Signal. 32:743–765. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Izzedine H and Perazella MA: Adverse kidney effects of epidermal growth factor receptor inhibitors. Nephrol Dial Transplant. 32:1089–1097. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Prieto-Lloret J and Aaronson PI: Hydrogen sulfide as an O2 sensor: A critical analysis. Adv Exp Med Biol. 967:261–276. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Olson KR: Hydrogen sulfide is an oxygen sensor in the carotid body. Respir Physiol Neurobiol. 179:103–110. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Olson KR: Hydrogen sulfide as an oxygen sensor. Antioxid Redox Signal. 22:377–397. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Olson KR: Hydrogen sulfide as an oxygen sensor. Clin Chem Lab Med. 51:623–632. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Evans RG, Smith DW, Khan Z, Ngo JP and Gardiner BS: Letter to the editor: ‘The plausibility of arterial-to-venous oxygen shunting in the kidney: It all depends on radial geometry’. Am J Physiol Renal Physiol. 309:F179–F180. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hirakawa Y, Tanaka T and Nangaku M: Renal hypoxia in CKD; pathophysiology and detecting methods. Front Physiol. 8:992017. View Article : Google Scholar : PubMed/NCBI | |
|
Koning AM, Frenay AR, Leuvenink HG and van Goor H: Hydrogen sulfide in renal physiology, disease and transplantation-the smell of renal protection. Nitric Oxide. 46:37–49. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q, Yu S, Zhang K, Zhang Z, Li C, Gao B, Zhang W and Wang Y: Exogenous H2S inhibits autophagy in unilateral ureteral obstruction mouse renal tubule cells by regulating the ROS-AMPK signaling pathway. Cell Physiol Biochem. 49:2200–2213. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lobb I, Sonke E, Aboalsamh G and Sener A: Hydrogen sulphide and the kidney: Important roles in renal physiology and pathogenesis and treatment of kidney injury and disease. Nitric Oxide. 46:55–65. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sekijima M, Sahara H, Miki K, Villani V, Ariyoshi Y, Iwanaga T, Tomita Y and Yamada K: Hydrogen sulfide prevents renal ischemia-reperfusion injury in CLAWN miniature swine. J Surg Res. 219:165–172. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Du Y, Liu XH, Zhu HC, Wang L, Wang ZS, Ning JZ and Xiao CC: Hydrogen sulfide treatment protects against renal ischemia-reperfusion injury via induction of heat shock proteins in rats. Iran J Basic Med Sci. 22:99–105. 2019.PubMed/NCBI | |
|
Tan Z, Shi Y, Yan Y, Liu W, Li G and Li R: Impact of endogenous hydrogen sulfide on toll-like receptor pathway in renal ischemia/reperfusion injury in rats. Ren Fail. 37:727–733. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lobb I, Jiang J, Lian D, Liu W, Haig A, Saha MN, Torregrossa R, Wood ME, Whiteman M and Sener A: Hydrogen sulfide protects renal grafts against prolonged cold ischemia-reperfusion injury via specific mitochondrial actions. Am J Transplant. 17:341–352. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmad A, Olah G, Szczesny B, Wood ME, Whiteman M and Szabo C: AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo. Shock. 45:88–97. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ling Q, Yu X, Wang T, Wang SG, Ye ZQ and Liu JH: Roles of the exogenous H2S-mediated SR-A signaling pathway in renal ischemia/reperfusion injury in regulating endoplasmic reticulum stress-induced autophagy in a rat model. Cell Physiol Biochem. 41:2461–2474. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Juriasingani S, Akbari M, Chan JY, Whiteman M and Sener A: H2S supplementation: A novel method for successful organ preservation at subnormothermic temperatures. Nitric Oxide. 81:57–66. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hosgood SA, van Heurn E and Nicholson ML: Normothermic machine perfusion of the kidney: Better conditioning and repair? Transpl Int. 28:657–664. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bagul A, Hosgood SA, Kaushik M, Kay MD, Waller HL and Nicholson ML: Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. Br J Surg. 95:111–118. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Nicholson ML and Hosgood SA: Renal transplantation after ex vivo normothermic perfusion: The first clinical study. Am J Transplant. 13:1246–1252. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hoyer DP, Gallinat A, Swoboda S, Wohlschläger J, Rauen U, Paul A and Minor T: Subnormothermic machine perfusion for preservation of porcine kidneys in a donation after circulatory death model. Transpl Int. 27:1097–1106. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cao X, Xiong S, Zhou Y, Wu Z, Ding L, Zhu Y, Wood ME, Whiteman M, Moore PK and Bian JS: Renal protective effect of hydrogen sulfide in cisplatin-induced nephrotoxicity. Antioxid Redox Signal. 29:455–470. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan Y, Zhu L, Li L, Liu J, Chen Y, Cheng J, Peng T and Lu Y: S-sulfhydration of SIRT3 by hydrogen sulfide attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury. Antioxid Redox Signal. 31:1302–1319. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cao X, Nie X, Xiong S, Cao L, Wu Z, Moore PK and Bian JS: Renal protective effect of polysulfide in cisplatin-induced nephrotoxicity. Redox Biol. 15:513–521. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Koike S, Ogasawara Y, Shibuya N, Kimura H and Ishii K: Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells. FEBS Lett. 587:3548–3555. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Waz S, Heeba GH, Hassanin SO and Abdel-Latif RG: Nephroprotective effect of exogenous hydrogen sulfide donor against cyclophosphamide-induced toxicity is mediated by Nrf2/HO-1/NF-κB signaling pathway. Life Sci. 264:1186302021. View Article : Google Scholar : PubMed/NCBI | |
|
Karimi A, Absalan F, Khorsandi L, Valizadeh A and Mansouri E: Sodium hydrogen sulfide (NaHS) ameliorates alterations caused by cisplatin in filtration slit diaphragm and podocyte cytoskeletal in rat kidney. J Nephropathol. 6:150–156. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Aziz NM, Elbassuoni EA, Kamel MY and Ahmed SM: Hydrogen sulfide renal protective effects: Possible link between hydrogen sulfide and endogenous carbon monoxide in a rat model of renal injury. Cell Stress Chaperones. 25:211–221. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Elbassuoni EA, Аziz NM and Habeeb WN: The role of activation of KАTP channels on hydrogen sulfide induced renoprotective effect on diabetic nephropathy. J Cell Physiol. 235:5223–5228. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmed HH, Taha FM, Omar HS, Elwi HM and Abdelnasser M: Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy. Mol Cell Biochem. 457:1–9. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Papu John AS, Kundu S, Pushpakumar S, Amin M, Tyagi SC and Sen U: Hydrogen sulfide inhibits Ca2+-induced mitochondrial permeability transition pore opening in type-1 diabetes. Am J Physiol Endocrinol Metab. 317:E269–E283. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Xiao T, Li F, Li Y, Zeng O, Liu M, Liang B, Li Z, Chu C and Yang J: Hydrogen sulfide reduced renal tissue fibrosis by regulating autophagy in diabetic rats. Mol Med Rep. 16:1715–1722. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Li L, Zeng O, Liu JM and Yang J: H2S improves renal fibrosis in STZ-induced diabetic rats by ameliorating TGF-β1 expression. Ren Fail. 39:265–272. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qian X, Li X, Ma F, Luo S, Ge R and Zhu Y: Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy. Biochem Biophys Res Commun. 473:931–938. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lin S, Visram F, Liu W, Haig A, Jiang J, Mok A, Lian D, Wood ME, Torregrossa R, Whiteman M, et al: GYY4137, a slow-releasing hydrogen sulfide donor, ameliorates renal damage associated with chronic obstructive uropathy. J Urol. 196:1778–1787. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lin S, Lian D, Liu W, Haig A, Lobb I, Hijazi A, Razvi H, Burton J, Whiteman M and Sener A: Daily therapy with a slow-releasing H2S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction. Nitric Oxide. 76:16–28. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yan X, Liao H, Cheng M, Shi X, Lin X, Feng XH and Chen YG: Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling. J Biol Chem. 291:382–392. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yan X and Chen YG: Smad7: Not only a regulator, but also a cross-talk mediator of TGF-β signalling. Biochem J. 434:1–10. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Y, Zhang Z, Huang Y, Mao Z, Yang X, Nakamura Y, Sawada N, Mitsui T, Takeda M and Yao J: Induction of inactive TGF-β1 monomer formation by hydrogen sulfide contributes to its suppressive effects on Ang II- and TGF-β1-induced EMT in renal tubular epithelial cells. Biochem Biophys Res Commun. 501:534–540. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Guo L, Peng W, Tao J, Lan Z, Hei H, Tian L, Pan W, Wang L and Zhang X: Hydrogen sulfide inhibits transforming growth factor-β1-induced EMT via Wnt/catenin pathway. PLoS One. 11:e01470182016. View Article : Google Scholar : PubMed/NCBI | |
|
John AMSP, Kundu S, Pushpakumar S, Fordham M, Weber G, Mukhopadhyay M and Sen U: GYY4137, a hydrogen sulfide donor modulates miR194-dependent collagen realignment in diabetic kidney. Sci Rep. 7:109242017. View Article : Google Scholar : PubMed/NCBI | |
|
Shevalye H, Maksimchyk Y, Watcho P and Obrosova IG: Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease. Biochim Biophys Acta. 1802:1020–1027. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nayak BK, Shanmugasundaram K, Friedrichs WE, Cavaglierii RC, Patel M, Barnes J and Block K: HIF-1 mediates renal fibrosis in OVE26 type 1 diabetic mice. Diabetes. 65:1387–1397. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HJ, Feliers D, Barnes JL, Oh S, Choudhury GG, Diaz V, Galvan V, Strong R, Nelson J, Salmon A, et al: Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience. 40:163–176. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HJ, Lee DY, Mariappan MM, Feliers D, Ghosh-Choudhury G, Abboud HE, Gorin Y and Kasinath BS: Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells. J Biol Chem. 292:5665–5675. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gu Y, Chen J, Zhang H, Shen Z, Liu H, Lv S, Yu X, Zhang D, Ding X and Zhang X: Hydrogen sulfide attenuates renal fibrosis by inducing TET-dependent DNA demethylation on Klotho promoter. FASEB J. 34:11474–11487. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Zhu X, Wang X, Peng Y, Du J, Yin H, Yang H, Ni X and Zhang W: H2S alleviates renal injury and fibrosis in response to unilateral ureteral obstruction by regulating macrophage infiltration via inhibition of NLRP3 signaling. Exp Cell Res. 387:1117792020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun HJ, Xiong SP, Cao X, Cao L, Zhu MY, Wu ZY and Bian JS: Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3. Redox Biol. 38:1018132021. View Article : Google Scholar : PubMed/NCBI | |
|
Pushpakumar S, Kundu S, Weber G and Sen U: Exogenous hydrogen sulfide and miR-21 antagonism attenuates macrophage-mediated inflammation in ischemia reperfusion injury of the aged kidney. Geroscience. 43:1349–1367. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HJ, Mariappan MM, Norton L, Bakewell T, Feliers D, Oh SB, Donati A, Rubannelsonkumar CS, Venkatachalam MA, Harris SE, et al: Proximal tubular epithelial insulin receptor mediates high-fat diet-induced kidney injury. JCI Insight. 6:e1436192021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu D, Gao B, Li M, Yao L, Wang S, Chen M, Li H, Ma C, Ji A and Li Y: Hydrogen sulfide mitigates kidney injury in high fat diet-induced obese mice. Oxid Med Cell Longev. 2016:27157182016. View Article : Google Scholar : PubMed/NCBI |
